Literature DB >> 12848625

Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

J Boudeau1, A-L Glasser, S Julien, J-F Colombel, A Darfeuille-Michaud.   

Abstract

BACKGROUND: Pathogenic adherent-invasive Escherichia coli have been isolated from ileal lesions of Crohn's disease. AIM: : To investigate the non-pathogenic E. coli strain Nissle 1917 (Mutaflor) as possible maintenance therapy in inflammatory bowel disease by testing its ability to prevent adherent-invasive E. coli strains from adhering to and invading human intestinal epithelial cells in vitro.
METHODS: Bacterial adhesion to and invasion of intestinal epithelial cells (Intestine-407) were assessed by counting the colony-forming units. The inhibitory effect of E. coli Nissle 1917 was determined after co-incubation with adherent-invasive E. coli strains or after pre-incubation of the intestinal epithelial cells with this probiotic strain prior to infection with adherent-invasive E. coli strains.
RESULTS: Strain Nissle 1917 exhibited dose- and time-dependent adherence to intestinal epithelial cells and inhibited the adhesion and invasion of various adherent-invasive E. coli strains. In co-infection experiments, the inhibitory effect on adherent-invasive E. coli adhesion reached 78-99.9%. Pre-incubation of intestinal epithelial cells with strain Nissle 1917 reduced adherent-invasive E. coli adhesion by 97.2-99.9%. The inhibitory effect on adherent-invasive E. coli invasion paralleled that on adhesion.
CONCLUSION: As strong and significant inhibitory effects on adherent-invasive E. coli adhesion and invasion were observed in co-infection and pre-infection experiments, E. coli Nissle 1917 could be efficient for preventive or curative probiotic therapy in patients with Crohn's disease.

Entities:  

Mesh:

Year:  2003        PMID: 12848625     DOI: 10.1046/j.1365-2036.2003.01638.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  61 in total

Review 1.  Probiotics in inflammatory bowel disease: is it all gut flora modulation?

Authors:  S Ghosh; D van Heel; R J Playford
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements.

Authors:  Philip M Sherman; Kathene C Johnson-Henry; Helen P Yeung; Peter S C Ngo; Jacques Goulet; Thomas A Tompkins
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 3.  Novel pathophysiological concepts of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Haruhiko Ogata
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

Review 4.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 5.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Authors:  Franco Scaldaferri; Viviana Gerardi; Francesca Mangiola; Loris Riccardo Lopetuso; Marco Pizzoferrato; Valentina Petito; Alfredo Papa; Jovana Stojanovic; Andrea Poscia; Giovanni Cammarota; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

6.  Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli.

Authors:  Ye Yang; Christian Jobin
Journal:  J Crohns Colitis       Date:  2015-03-10       Impact factor: 9.071

Review 7.  The role of probiotics in management of irritable bowel syndrome.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Curr Gastroenterol Rep       Date:  2007-10

8.  NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors:  Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

10.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Authors:  Frédéric A Carvalho; Nicolas Barnich; Adeline Sivignon; Claude Darcha; Carlos H F Chan; Clifford P Stanners; Arlette Darfeuille-Michaud
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.